Komrokji, Rami S., Hetty E. Carraway, Ulrich Germing, Martin Wermke, Amer M. Zeidan, Eric Fu, Björn Rüter, Ute Burkard, Annika Osswald, and James M. Foran. 2022. “A Phase I/II Multicenter, Open-Label, Dose Escalation and Randomized Trial of BI 836858 in Patients With Low- or Intermediate-1-Risk Myelodysplastic Syndrome”. Haematologica 107 (11). Pavia, Italy, 2742-47. https://doi.org/10.3324/haematol.2021.280500.